Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays

Chiara Gabbiani, Guido Mastrobuoni, Francesca Sorrentino, Barbara Dani, Maria Pia Rigobello, Alberto Bindoli, Maria Agostina Cinellu, Giuseppe Pieraccini, Luigi Messori, Angela Casini
  • MedChemComm, January 2011, Royal Society of Chemistry
  • DOI: 10.1039/c0md00181c
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Professor Maria Agostina Cinellu